Literature DB >> 20489080

Role of MRI in follow-up after focal therapy for prostate carcinoma.

Pieter J De Visschere1, Gert O De Meerleer, Jurgen J Fütterer, Geert M Villeirs.   

Abstract

OBJECTIVE: In patients with clinically suspected local recurrence of prostate cancer, a lobulated hyperintense mass in the radical prostatectomy fossa can be readily visualized with T2-weighted MRI, but this imaging technique is less successful after treatments such as radiation therapy, high-intensity focused ultrasound, and cryosurgery. We describe the additional value of functional techniques in the assessment of local recurrence.
CONCLUSION: The use of functional MRI techniques such as MR spectroscopy, diffusion-weighted imaging, and dynamic contrast-enhanced MRI has shown promise in increasing overall imaging performance in the detection of local recurrence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489080     DOI: 10.2214/AJR.10.4263

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  22 in total

1.  Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.

Authors:  David M Schuster; Bital Savir-Baruch; Peter T Nieh; Viraj A Master; Raghuveer K Halkar; Peter J Rossi; Melinda M Lewis; Jonathon A Nye; Weiping Yu; F DuBois Bowman; Mark M Goodman
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.

Authors:  Chiara Fuccio; Riccardo Schiavina; Paolo Castellucci; Domenico Rubello; Giuseppe Martorana; Monica Celli; Claudio Malizia; Marta Barios Profitos; Maria Cristina Marzola; Vincenzina Pettinato; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

Review 3.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

4.  Temporal changes in MRI appearance of the prostate after focal ablation.

Authors:  Andreas M Hötker; Andreas Meier; Yousef Mazaheri; Junting Zheng; Marinela Capanu; Joshua Chaim; Ramon Sosa; Jonathan Coleman; Hedvig Hricak; Oguz Akin
Journal:  Abdom Radiol (NY)       Date:  2019-01

5.  [Multiparametric prostate MRI for follow-up monitoring after radiation therapy].

Authors:  A M Weidner; D J Dinter; M Bohrer; M Sertdemir; D Hausmann; F Wenz; S O Schoenberg
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

6.  3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy.

Authors:  Clément Orczyk; Andrew B Rosenkrantz; Artem Mikheev; Arnauld Villers; Myriam Bernaudin; Samir S Taneja; Samuel Valable; Henry Rusinek
Journal:  Acad Radiol       Date:  2017-11-06       Impact factor: 3.173

7.  Focal therapy for prostate cancer - where are we in 2011?

Authors:  Michael S Borofsky; Timothy Ito; Andrew B Rosenkrantz; Samir S Taneja
Journal:  Ther Adv Urol       Date:  2011-08

8.  Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.

Authors:  Christian Uprimny; Alexander Stephan Kroiss; Clemens Decristoforo; Josef Fritz; Boris Warwitz; Lorenza Scarpa; Llanos Geraldo Roig; Dorota Kendler; Elisabeth von Guggenberg; Jasmin Bektic; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-29       Impact factor: 9.236

9.  Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.

Authors:  Christian Uprimny; Alexander Stephan Kroiss; Josef Fritz; Clemens Decristoforo; Dorota Kendler; Elisabeth von Guggenberg; Bernhard Nilica; Johanna Maffey-Steffan; Gianpaolo di Santo; Jasmin Bektic; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-06       Impact factor: 9.236

Review 10.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.

Authors:  Yu Xuan Kitzing; Adilson Prando; Celi Varol; Gregory S Karczmar; Fiona Maclean; Aytekin Oto
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.